Events & Webinars, Hot Topics, Latest News,
Australia as a Strategic Gateway for Pharmacovigilance Leadership in APAC: Reflections from the ARCS Conference 2025
Explore how Australia’s people, partnerships, and regulatory strength position it as a leader in pharmacovigilance across the Asia-Pacific…
Cyclone Alfred: A Wake-Up Call to Strengthen Temperature Excursion Protocols and Elevate Medical Information Services
A strategic step forward for Australia’s digital and connected health sector. At Commercial Eyes, we believe in the power of collaboration. Today, we are proud to announce a strategic…
Commercial Eyes is backing Australia’s digital health vision through its partnership with ANDHealth
A strategic step forward for Australia’s digital and connected health sector. At Commercial Eyes, we believe in the power of collaboration. Today, we are proud to announce a strategic…
Celebrating Our EcoVadis Silver Medal
Our ongoing commitment to sustainability and ethical practices has led us to achieve the EcoVadis Silver rating after only our second year! This milestone reflects our dedication to continuous improvement…
Health innovation trends for 2025: The era of personalisation, precision, and patient empowerment
As health innovation continues to accelerate, 2025 will be another transformative year, driven by several major trends that combine and overlap technology, personalisation, and sustainability. Based on everything we have learned…
Season’s Greetings from Commercial Eyes!
We wish you and your loved ones a holiday filled with peace, joy, and cherished moments – and a New Year that brings health, happiness, and…
Understanding Risk Management Programs: Ensuring Patient Safety, Regulatory Compliance, and Optimized Therapy
Part 5 of 6: A poorly implemented Risk Management Program (RMP) can erode trust, increase risks, and jeopardise outcomes. Learn how thoughtful design and technology can enhance patient safety, regulatory…
Understanding the unique value proposition and buyer segmentation to develop investor ready research for a global hardware and SaMD company
Commercial Eyes’ client, Vitrafy has successfully completed their initial public offering (IPO) on the Australian Securities Exchange (ASX). We unpack the work Commercial Eyes delivered to inform and support the development…
Making the Right Call: Commercial Eyes’ Expertise in Assessing In-Licensing Opportunities
At Commercial Eyes, we empower our clients to make informed, confident decisions about whether to license a product by offering comprehensive, data-driven assessments that balance clinical promise with commercial viability….